Downregulation of matrix metalloproteinase-9 and attenuation of edema via inhibition of ERK mitogen activated protein kinase in traumatic brain injury

Journal of Neurotrauma

Volumn 19, Issue 11, 2002, Pages 1411-1419

  Mori, Tatsuro ^a   Wang, Xiaoying ^a   Aoki, Toshiaki ^a   Lo, Eng H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood brain barrier; Mouse; Neuroprotection; Proteolysis

Indexed keywords

GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INJURY; CATALYSIS; CONTROLLED STUDY; EDEMA; ENZYME INHIBITION; EXTRACELLULAR MATRIX; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FAMILY; RECEPTOR DOWN REGULATION; TIGHT JUNCTION; TISSUE INJURY;

EID: 0036858359     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771502320914642     Document Type: Article

References (59)

1. Alessandrini, A., Namura, S., Moskowitz, M.A., et al. (1999). MEK1 protein kinase inhibition protects against damage from focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 96, 12866-12869.
2. Asahi, M., Asahi, K., Jung, J.C., et al. (2000). Role of matrix metalloproteinase 9 in focal cerebral ischemia: Effects of gene knockout and enzyme inhibition with BB-94. J. Cereb. Blood Flow Metab. 20, 1681-1690.
3. Asahi, M., Sumii, T., Fini, M.E., et al. (2001a). Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 12, 3003-3007.
4. Asahi, M., Wang, X., Mori, T., et al. (2001b). Effects of matrix metalloproteinase 9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21, 7724-7732.
5. Bhat, N.R., and Zhang, P. (1999). Hydrogen peroxide activation of multiple mitogen activated protein kinases in oligodendrocytes: Role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72, 112-119.
6. Cho, A., Graves, J., and Reidy, M.A. (2000). Mitogen activated protein kinase mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 2527-2531.
7. Datta, S.R., Brunet, A., and Greenberg, M.E. (1999). Cellular survival: A play in three Akts. Genes Dev. 13, 2905-2927.
8. Denker, B.M., and Nigam, S.K. (1998). Molecular structure and assembly of the tight junction. Am. J. Physiol. 274, FI-F9.
9. Favata, M.F., Horuichi, K.Y., Manos, E.J., et al. (1998). Identification of a novel inhibitor of mitogen activated protein kinase kinase. J. Biol. Chem. 273, 18623-18632.
10. Ferguson, T.A., and Muir, D. (2000). MMP-2 and MMP-9 increase the neurite-promoting potential of schwann cell basal laminae and are upregulated in degenerated nerve. Mol. Cell Neurosci. 16, 157-167.
11. Fini, M.E., Cook, J.R., Mohan, R., et al. (1998). Regulation of matrix metalloproteinase gene expression, in: Matrix Metalloproteinases. W.C. Parks and R.P. Mecham (eds), Academic Press: New York, pps. 299-356.
12. Garrington, T.P., and Johnson, G.L. (1999). Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell. Biol. 11, 211-218.
13. Gasche, Y., Copin, J.C., Sugawara, T., et al. (2001). Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab 21, 1393-1400.
14. Gasche, Y., Fujimura, Y., Copin, J., et al. (1999). Early appearance of activated MMP-9 after focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 1020-1028.
15. Genersch, E., Haye, K., Neuenfeld, Y., et al. (2000). Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells. J. Cell Sci. 113, 4319-4330.
16. Gonzalez-Zulueta, M., Feldman, A.B., Klesse, L.J., et al. (2000). Requirement for nitric oxide activation of p21(ras)/xtracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. U.S.A. 97, 436-441.
17. 2: Role in cell survival following oxidant injury. J. Biol. Chem. 271, 4138-4142.
18. Harkness, K.A., Adamson, P., Sussman, J.D., et al. (2000). Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain 123, 698-709.
19. Hartung, H.P., and Kieseier, B.C. 2000). The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J. Neuroimmunol. 107, 140-147.
20. Heo, J.H., Lucero, J., Abumiya, T., et al. (1999). Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19, 624-633.
21. Hu, B.R., Liu, C.L., and Park, D.L. (2000). Alteration of MAP kinase pathways after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 20, 1089-1095.
22. Huber, J.D., Egleton, R.D., and Davis, T.P. (2001). Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24, 719-725.
23. Kniesel, U., and Wolburg, H. (2000). Tight junctions of the blood-brain barrier. Cell Mol. Neurobiol. 20, 57-76.
24. Kulich, S.M., and Chu, C.T. (2001). Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: Implications for Parkinson's disease. J. Neurochem. 77, 1058-1066.
25. Lewen, A., Matz, P., and Chan, P.H. (2000). Free radical pathways in CNS injury. J. Neurotrauma 17, 871-891.
26. Lo, E.H., Wang, X., and Cuzner, M.L. (2002). Extracellular proteolysis in brain injury and inflammation: Role for plasminogen activators and matrix metalloproteinases. J. Neurosci. Res. 69, 1-9.
27. Lukashev, M.E., and Werb, Z. (1998). ECM signalling: Orchestrating cell behavior and misbehavior. Trends Cell Biol. 8, 437-441.
28. Marmarou, A. (1996). Pathophysiology of intracranial pressure, in: Neurotrauma. R.K. Narayan, J.E. Wilberger, and J.T. Povlishock (eds), McGraw-Hill: New York, pps. 413-429.
29. Mielke, K., and Herdegen, T. (2000). JNK and p38 stress kinases: Degenerative effectors of signal transduction cascades in the nervous system. Prog. Neurobiol. 61, 45-60.
30. Mori, T., Wang, X., Jung, J., et al. (2002). Mitogen activated protein kinase inhibition for traumatic brain injury: In vitro and in vivo effects. J. Cereb. Blood Flow Metab. 22, 444-452.
31. Mori, T., Wang, X., Kline, A.E., et al. (2001). Reduced cortical injury and edema in tissue plasminigen activator knockout mice after brain trauma. Neuroreport 12, 4117-4120.
32. Morita-Fujimura, Y., Fujimura, M., Gasche, Y., et al. (1999). Overexpression of copper and zinc superoxide dismutase in transgenic mice prevents the induction and activation of matrix metalloproteinases after cold injury induced brain trauma. J. Cereb. Blood Flow Metab. 20, 130-138.
33. Mun-Bryce, S., and Rosenberg, G.A. (1998a). Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274, RI203-RI211.
34. Mun-Bryce, S., and Rosenberg, G.A. (1998b). Matrix metalloproteinases in cerebrovascular disease. J. Cereb. Blood Flow Metab. 18, 1163-1172.
35. Murray, B., Alessandrini, A., Cole, A.J., et al. (1998). Inhibition of the p44/42 ERK/AP kinase pathway protects hippocampal neurons in a cell culture model of seizure activity. Proc. Natl. Acad. Sci. U.S.A. 95, 11975-11980.
36. Nagase, H., Woessner, J.F. (1999). Matrix metalloproteinases: A minireview. J. Biol. Chem. 274, 21491-21494.
37. Namura, S., Ihara, K., Takami, S., et al. (2001). Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 98, 11569-11574.
38. Nico, B., Quondamatteo, F., Herken, R., et al. (1999). Developmental expression of ZO-1 antigen in the mouse blood-brain barrier. Brain Res. Dev. Brain Res. 114, 161-169.
39. Oh, L.Y.S., Larsen, P.H., Krekoski, C.A., et al. (1999). Matrix metalloproteinase-9/elatinase B is required for process outgrowth by oligodendrocytes. J. Neurosci. 19, 8464-8475.
40. Pepper, M.S. (2001). Role of the matrix metalloproteinase and plasmminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 21, 1104-1117.
41. Raghupathi, R., Graham, D.I., and McIntosh, T.K. (2000). Apoptosis after traumatic brain injury. J. Neurotrauma. 17, 927-940.
42. Regan, R.F., Wang, Y., Ma, X., et al. (2001). Activation of ERK potentiates hemin toxicity in astrocyte cultures. J. Neurochem. 79, 545-555.
43. Romanic, A.M., White, R.F., Arleth, A.J., et al. (1998). Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. Stroke 29, 1020-1030.
44. Rosenberg, G.A., Estrada, E.Y., and Dencoff, J.E. (1998). Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29, 2189-2195.
45. Rosenberg, G.A., and Navaratil, M. (1997). Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48, 921-926.
46. Rosenberg, G.A., Navratil, M., Barone, F., et al. (1996). Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16, 360-366.
47. Smith, D.H., and McIntosh, T.K. Traumatic brain injury and excitatory amino acids, in: Neurotrauma. R.K. Narayan, J.E. Wilberger, and J.T. Povlishock (eds), McGraw-Hill: New York, pps. 1445-1458.
48. Stanciu, M., Wang, Y., Kentor, R., et al. (2000). Persistent activation of ERK contributes to glutamate induced oxidative toxicity in a neuronal cell line and primary neuron cultures. J. Biol. Chem. 275, 12200-12206.
49. Sugino, T., Nozaki, K., Takagi, Y., et al. (2000). Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J. Neurosci. 20, 4506-4514.
50. Vecil, G.G., Larsen, P.H., Corley, S.M., et al. (2000). Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61, 212-224.
51. Vu, T.H., and Werb, Z. (1998). Gelatinase B: Structure, regulation and function, in: Matrix Metalloproteinases. W.C. Parks and R.P. Mecham (eds), Academic Press: New York, pps. 115-137.
52. Wang, X., Jung, J., Asahi, M., et al. (2000). Effects of matrix metalloproteinase 9 gene knockout on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20, 7037-7043.
53. Wang, X., Mori, T., Jung, J., et al. (2002). Secretion of matrix metalloproteinase-2 and -9 following traumatic injury in rat cortical cultures and involvement of MAP kinase. J. Neurotrauma 19, 615-625.
54. Westermarck, J., and Kahari, W. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.
55. Xia, Z., Dickens, M., Rainegaud, J., et al. (1995). Opposing effects of ERK and JUNK/38 MAP kinase on apoptosis. Science 270, 1326-1331.
56. Xu, J., Kim, G., Ahmed, S.H., et al. (2001). Glucocorticoid receptor mediated suppression of activator protein 1 activation and matrix metalloproteinase expression after spinal cord injury. J. Neurosci. 21, 92-97.
57. Yong, V.W., Krekoski, C.A., Forsyth, P.A., et al. (1998). Matrix metalloproteinases and disease of the CNS. Trends Neurosci. 21, 75-80.
58. Yong, V.W., Power, C., Forsyth, P., et al. (2001). Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511.
59. Zhang, Z.G., Zhang, L., Tsang, W., et al. (2001). Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res. 912, 181-194.